Annovis Total Current Liabilities vs Other Current Liab Analysis

ANVS Stock

USD 6.11 0.54 9.69%

Annovis BioInc financial indicator trend analysis is way more than just evaluating Annovis BioInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Annovis BioInc is a good investment. Please check the relationship between Annovis BioInc Total Current Liabilities and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.

Total Current Liabilities vs Other Current Liab

Total Current Liabilities vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Annovis BioInc Total Current Liabilities account and Other Current Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Annovis BioInc's Total Current Liabilities and Other Current Liab is 0.63. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Annovis BioInc, assuming nothing else is changed. The correlation between historical values of Annovis BioInc's Total Current Liabilities and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Annovis BioInc are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Total Current Liabilities i.e., Annovis BioInc's Total Current Liabilities and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Annovis BioInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Annovis BioInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Liab

Most indicators from Annovis BioInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Annovis BioInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.At this time, Annovis BioInc's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 171.1 M in 2024, whereas Discontinued Operations is likely to drop (6.3 M) in 2024.

	2021	2022	2023	2024 (projected)
Research Development	8.5M	16.5M	38.8M	40.7M
Other Operating Expenses	14.5M	25.5M	45.0M	47.3M

Research Development Other Operating Expenses

Annovis BioInc fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Assets	Good Will	Net Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Net Invested Capital
Total Assets		0.47	0.62	0.92	0.75	-0.36	0.52	0.93	0.21	-0.03	0.53	0.65	-0.04	0.99	0.12	-0.15	0.23	0.19	-0.15	-0.92	0.92	0.67	0.62	-0.34	0.7	0.89
Other Current Liab	0.47		0.63	0.16	0.83	-0.89	0.29	0.42	-0.2	-0.27	0.62	0.89	0.67	0.5	-0.42	-0.23	-0.2	-0.15	-0.3	-0.39	0.38	0.78	0.81	0.44	0.86	0.28
Total Current Liabilities	0.62	0.63		0.42	0.59	-0.47	0.91	0.35	0.54	0.13	0.64	0.52	0.39	0.55	0.36	-0.2	0.57	0.49	-0.26	-0.32	0.32	0.45	0.53	0.14	0.51	0.29
Total Stockholder Equity	0.92	0.16	0.42		0.5	-0.03	0.41	0.89	0.21	0.1	0.48	0.36	-0.42	0.91	0.24	0.0	0.21	0.15	0.02	-0.9	0.9	0.44	0.39	-0.64	0.43	0.93
Net Tangible Assets	0.75	0.83	0.59	0.5		-0.88	0.34	0.69	-0.05	-0.09	0.38	0.98	0.45	0.76	-0.24	-0.12	-0.03	0.05	-0.21	-0.66	0.65	0.94	0.86	0.23	0.98	0.54
Retained Earnings	-0.36	-0.89	-0.47	-0.03	-0.88		-0.18	-0.31	0.15	0.17	-0.21	-0.93	-0.75	-0.37	0.43	0.2	0.15	0.06	0.32	0.27	-0.26	-0.84	-0.8	-0.61	-0.89	-0.12
Accounts Payable	0.52	0.29	0.91	0.41	0.34	-0.18		0.19	0.82	0.36	0.41	0.22	0.19	0.41	0.69	-0.13	0.85	0.76	-0.16	-0.17	0.16	0.18	0.22	0.03	0.21	0.16
Cash	0.93	0.42	0.35	0.89	0.69	-0.31	0.19		-0.11	-0.24	0.48	0.63	-0.12	0.97	-0.15	-0.15	-0.1	-0.14	-0.13	-1.0	1.0	0.68	0.63	-0.45	0.7	0.97
Net Receivables	0.21	-0.2	0.54	0.21	-0.05	0.15	0.82	-0.11		0.52	-0.08	-0.18	-0.03	0.09	0.81	-0.2	0.98	0.82	-0.22	0.12	-0.12	-0.2	-0.21	-0.02	-0.19	-0.11
Inventory	-0.03	-0.27	0.13	0.1	-0.09	0.17	0.36	-0.24	0.52		-0.17	-0.24	-0.36	-0.13	0.69	0.57	0.49	0.67	0.53	0.24	-0.25	-0.28	-0.33	0.08	-0.25	-0.24
Other Current Assets	0.53	0.62	0.64	0.48	0.38	-0.21	0.41	0.48	-0.08	-0.17		0.37	0.02	0.55	-0.07	-0.09	-0.07	-0.12	-0.06	-0.49	0.49	0.35	0.44	-0.23	0.39	0.53
Other Stockholder Equity	0.65	0.89	0.52	0.36	0.98	-0.93	0.22	0.63	-0.18	-0.24	0.37		0.56	0.67	-0.39	-0.18	-0.17	-0.09	-0.27	-0.6	0.59	0.95	0.89	0.32	1.0	0.47
Total Liab	-0.04	0.67	0.39	-0.42	0.45	-0.75	0.19	-0.12	-0.03	-0.36	0.02	0.56		-0.04	-0.32	-0.37	0.01	0.02	-0.45	0.17	-0.17	0.39	0.46	0.83	0.5	-0.32
Total Current Assets	0.99	0.5	0.55	0.91	0.76	-0.37	0.41	0.97	0.09	-0.13	0.55	0.67	-0.04		0.0	-0.17	0.1	0.05	-0.17	-0.96	0.96	0.7	0.66	-0.37	0.73	0.93
Intangible Assets	0.12	-0.42	0.36	0.24	-0.24	0.43	0.69	-0.15	0.81	0.69	-0.07	-0.39	-0.32	0.0		0.35	0.87	0.9	0.36	0.16	-0.15	-0.39	-0.41	-0.19	-0.39	-0.1
Common Stock	-0.15	-0.23	-0.2	0.0	-0.12	0.2	-0.13	-0.15	-0.2	0.57	-0.09	-0.18	-0.37	-0.17	0.35		-0.11	0.27	0.98	0.14	-0.14	-0.2	-0.22	0.0	-0.18	-0.12
Property Plant Equipment	0.23	-0.2	0.57	0.21	-0.03	0.15	0.85	-0.1	0.98	0.49	-0.07	-0.17	0.01	0.1	0.87	-0.11		0.88	-0.13	0.12	-0.12	-0.18	-0.2	-0.01	-0.17	-0.1
Other Assets	0.19	-0.15	0.49	0.15	0.05	0.06	0.76	-0.14	0.82	0.67	-0.12	-0.09	0.02	0.05	0.9	0.27	0.88		0.26	0.16	-0.17	-0.13	-0.21	0.14	-0.1	-0.18
Good Will	-0.15	-0.3	-0.26	0.02	-0.21	0.32	-0.16	-0.13	-0.22	0.53	-0.06	-0.27	-0.45	-0.17	0.36	0.98	-0.13	0.26		0.12	-0.12	-0.27	-0.31	-0.1	-0.26	-0.09
Net Debt	-0.92	-0.39	-0.32	-0.9	-0.66	0.27	-0.17	-1.0	0.12	0.24	-0.49	-0.6	0.17	-0.96	0.16	0.14	0.12	0.16	0.12		-1.0	-0.65	-0.61	0.48	-0.67	-0.98
Cash And Short Term Investments	0.92	0.38	0.32	0.9	0.65	-0.26	0.16	1.0	-0.12	-0.25	0.49	0.59	-0.17	0.96	-0.15	-0.14	-0.12	-0.17	-0.12	-1.0		0.64	0.61	-0.49	0.66	0.98
Common Stock Total Equity	0.67	0.78	0.45	0.44	0.94	-0.84	0.18	0.68	-0.2	-0.28	0.35	0.95	0.39	0.7	-0.39	-0.2	-0.18	-0.13	-0.27	-0.65	0.64		0.89	0.1	0.96	0.56
Common Stock Shares Outstanding	0.62	0.81	0.53	0.39	0.86	-0.8	0.22	0.63	-0.21	-0.33	0.44	0.89	0.46	0.66	-0.41	-0.22	-0.2	-0.21	-0.31	-0.61	0.61	0.89		0.15	0.9	0.52
Non Current Liabilities Total	-0.34	0.44	0.14	-0.64	0.23	-0.61	0.03	-0.45	-0.02	0.08	-0.23	0.32	0.83	-0.37	-0.19	0.0	-0.01	0.14	-0.1	0.48	-0.49	0.1	0.15		0.24	-0.64
Capital Surpluse	0.7	0.86	0.51	0.43	0.98	-0.89	0.21	0.7	-0.19	-0.25	0.39	1.0	0.5	0.73	-0.39	-0.18	-0.17	-0.1	-0.26	-0.67	0.66	0.96	0.9	0.24		0.54
Net Invested Capital	0.89	0.28	0.29	0.93	0.54	-0.12	0.16	0.97	-0.11	-0.24	0.53	0.47	-0.32	0.93	-0.1	-0.12	-0.1	-0.18	-0.09	-0.98	0.98	0.56	0.52	-0.64	0.54

Click cells to compare fundamentals

Annovis BioInc Account Relationship Matchups

Annovis BioInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1M	8.1M	46.0M	36.0M	10.2M	14.9M
Other Current Liab	776.9K	236.5K	818.4K	3.7M	3.0M	3.1M
Total Current Liabilities	2.0M	578.4K	1.5M	7.7M	4.3M	3.0M
Total Stockholder Equity	(8.6M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Tangible Assets	(7.6M)	(8.6M)	7.5M	44.5M	51.2M	53.7M
Retained Earnings	(8.8M)	(14.2M)	(28.7M)	(54.1M)	(110.3M)	(104.7M)
Accounts Payable	1.2M	341.9K	688.1K	4.0M	1.3M	1.5M
Cash	1.9K	8.1M	45.7M	28.4M	5.8M	9.4M
Other Current Assets	745.7M	44.7M	315.5M	7.6B	4.5M	4.2M
Other Stockholder Equity	200.6K	21.8M	73.2M	82.4M	102.5M	107.6M
Total Liab	9.7M	578.4K	1.5M	7.7M	18.0M	18.9M
Total Current Assets	747.5K	8.1M	46.0M	36.0M	10.2M	12.9M
Net Debt	497.9K	(8.1M)	(45.7M)	(28.4M)	(5.8M)	(6.0M)
Cash And Short Term Investments	1.9K	8.1M	45.7M	28.4M	5.8M	5.5M
Common Stock Shares Outstanding	6.8M	6.3M	7.6M	8.2M	9.0M	7.3M
Liabilities And Stockholders Equity	1.1M	8.1M	46.0M	36.0M	10.2M	16.0M
Non Current Liabilities Total	7.7M	341.9K	688.1K	4.0M	13.7M	14.4M
Capital Surpluse	192.1K	200.6K	21.8M	73.2M	84.2M	88.4M
Net Invested Capital	(8.1M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Working Capital	(1.3M)	7.5M	44.5M	28.3M	5.9M	5.6M

Pair Trading with Annovis BioInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.

Moving against Annovis Stock

0.5	MBRX	Moleculin Biotech Financial Report 9th of May 2024	Pair Corr
0.45	LFCR	Lifecore Biomedical Financial Report 6th of June 2024	Pair Corr

The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.

The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Annovis BioInc is a strong investment it is important to analyze Annovis BioInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Annovis BioInc's future performance. For an informed investment choice regarding Annovis Stock, refer to the following important reports:

How To Invest In Annovis

Details

Is Annovis Stock a good investment?

Details

What is Annovis BioInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Annovis Stock analysis

When running Annovis BioInc's price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.23)

Return On Assets

(1.22)

Return On Equity

(5.46)

The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Annovis Total Current Liabilities vs Other Current Liab Analysis

Total Current Liabilities vs Other Current Liab

Total Current Liabilities vs Other Current Liab Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Other Current Liab

Annovis BioInc fundamental ratios Correlations

Annovis BioInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Annovis BioInc fundamental ratios Accounts

Pair Trading with Annovis BioInc

Moving against Annovis Stock

Complementary Tools for Annovis Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Capital Surpluse	+ 1.0	Other Stockholder Equity
Total Current Assets	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.98	Net Tangible Assets
Capital Surpluse	+ 0.98	Net Tangible Assets
Property Plant Equipment	+ 0.98	Net Receivables

Cash And Short Term Investments	- 1.0	Net Debt
Net Debt	- 1.0	Cash
Net Invested Capital	- 0.98	Net Debt
Net Debt	- 0.96	Total Current Assets
Other Stockholder Equity	- 0.93	Retained Earnings
Net Debt	- 0.92	Total Assets